Grantclosed🌐 United StatesPAR-25-329

Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Jan 3, 2025
Response deadline: Aug 11, 2025, 12:00 AM UTC
Type: Grant
Category: 93.279
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-329

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
United States · Jan 3, 2025
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
United States · Jul 12, 2024
NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
United States · Nov 21, 2024
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
United States · Sep 28, 2023
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
United States · Sep 28, 2023

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.